EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Probing the Histamine H 1 Receptor Binding Site to Explore Ligand Binding Kinetics

Sebastiaan Kuhne, Reggie Bosma, Albert J Kooistra, Rick Riemens, Marc C M Stroet, Henry F Vischer iD, Chris de Graaf iD, Maikel Wijtmans iD, Rob Leurs iD, Iwan J P de Esch iD

Journal of Medicinal Chemistry · 09.01.2025 · 68 (1) · 448-464

DOI: 10.1021/acs.jmedchem.4c02043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 26.12.2024. Verfasst von Sebastiaan Kuhne und 9 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam Institute of Molecular and Life Sciences (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boe…. Hauptthemen laut MEDLINE: Receptors, Histamine H1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative, European Cooperation in Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Analysis of structure-kinetic relationships (SKR) can contribute to an improved understanding of receptor-ligand interactions. Here, fragment 1 (4-(2-benzylphenoxy)-1-methylpiperidine) was used in different fragment growing approaches to mimic the putative binding mode of the long residence time (RT) ligands olopatadine, acrivastine, and levocetirizine at the histamine H1 receptor (H1R). SKR analyses reveal that introduction of a carboxylic acid moiety can increase RT at H1R up to 11-fold. Ligand efficiency (LE) decreases upon the introduction of the negatively charged group, whereas kinetic efficiency (KE) increases up to 8.5-fold. The olopatadine/acrivastine mimics give up to 15-fold differences in the RT, while the levocetirizine mimics afford similar RTs with only a 3-fold difference. Therefore, the levocetirizine mimics are less sensitive to structural changes. This study illustrates that for H1R, there are several ways to increase RT but the different strategies differ significantly in SKR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Histamine H1LigandsKineticsBinding SitesHumansStructure-Activity RelationshipCetirizinePiperidinesAnimalsOlopatadine HydrochlorideProtein BindingHistamine H1 AntagonistsCricetulus

Substanzen

LigandsReceptors, Histamine H1CetirizinePiperidineslevocetirizineOlopatadine HydrochlorideHistamine H1 Antagonists

Autor:innen und Institutionen

  • Amsterdam Institute of Molecular and Life Sciences (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands.

ORCID-Profile: Henry F Vischer, Chris de Graaf, Maikel Wijtmans, Rob Leurs, Iwan J P de Esch

Förderung

  • Innovative Medicines Initiative
  • European Cooperation in Science and Technology

Zitieren

APA

Kuhne, S., Bosma, R., Kooistra, A. J., Riemens, R., Stroet, M. C. M., Vischer, H. F., de Graaf, C., Wijtmans, M., Leurs, R., & de Esch, I. J. P. (2025). Probing the Histamine H 1 Receptor Binding Site to Explore Ligand Binding Kinetics. Journal of Medicinal Chemistry, 68(1), 448-464. https://doi.org/10.1021/acs.jmedchem.4c02043

Vancouver

Kuhne S, Bosma R, Kooistra AJ, Riemens R, Stroet MCM, Vischer HF, et al. Probing the Histamine H 1 Receptor Binding Site to Explore Ligand Binding Kinetics. Journal of Medicinal Chemistry. 2025;68(1):448-464. doi:10.1021/acs.jmedchem.4c02043

BibTeX
@article{Kuhne2025,
  author = {Kuhne, Sebastiaan and Bosma, Reggie and Kooistra, Albert J and Riemens, Rick and Stroet, Marc C M and Vischer, Henry F and de Graaf, Chris and Wijtmans, Maikel and Leurs, Rob and de Esch, Iwan J P},
  title = {Probing the Histamine H 1 Receptor Binding Site to Explore Ligand Binding Kinetics},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {1},
  pages = {448--464},
  doi = {10.1021/acs.jmedchem.4c02043}
}
Kostenlos starten →